GapDB find and trade gaps by statistics
Biotech IBB+XBI 1Y Gap Scan
Updated 2021-03-03
click to sort
| Company | Symbol | TotalGap | FilledGap | UnfilledGap | UnfilledPct |
|---|---|---|---|---|---|
| Blueprint Medicines Corp | BPMC | 7 | 6 | 1 | 14.3 |
| Protagonist Therapeutics Inc | PTGX | 5 | 3 | 2 | 40.0 |
| Omeros Corporation | OMER | 7 | 6 | 1 | 14.3 |
| Sutro Biopharma Inc | STRO | 6 | 4 | 2 | 33.3 |
| Amicus Therapeutics Inc | FOLD | 4 | 4 | 0 | 0.0 |
| Halozyme Therapeutics Inc. | HALO | 5 | 3 | 2 | 40.0 |
| Esperion Therapeutics Inc. | ESPR | 1 | 1 | 0 | 0.0 |
| Grifols SA - ADR - Level III | GRFS | 15 | 15 | 0 | 0.0 |
| Collegium Pharmaceutical Inc | COLL | 6 | 6 | 0 | 0.0 |
| UroGen Pharma Ltd | URGN | 5 | 5 | 0 | 0.0 |
| Hutchison China Meditech Ltd. - ADR | HCM | 2 | 0 | 2 | 100.0 |
| Poseida Therapeutics Inc | PSTX | 1 | 1 | 0 | 0.0 |
| Applied Molecular Transport Inc | AMTI | 1 | 1 | 0 | 0.0 |
| Twist Bioscience Corp | TWST | 15 | 10 | 5 | 33.3 |
| Biomarin Pharmaceutical Inc. - Registered Shares | BMRN | 10 | 10 | 0 | 0.0 |
| Biocryst Pharmaceuticals Inc. | BCRX | 11 | 6 | 5 | 45.5 |
| Invitae Corp | NVTA | 15 | 10 | 5 | 33.3 |
| Phibro Animal Health Corp. - Class A | PAHC | 5 | 5 | 0 | 0.0 |
| Adaptive Biotechnologies Corp | ADPT | 4 | 4 | 0 | 0.0 |
| Nanostring Technologies Inc | NSTG | 8 | 6 | 2 | 25.0 |
| Harpoon Therapeutics Inc | HARP | 6 | 4 | 2 | 33.3 |
| Adverum Biotechnologies Inc | ADVM | 6 | 5 | 1 | 16.7 |
| Ovid Therapeutics Inc | OVID | 3 | 3 | 0 | 0.0 |
| Immunogen, Inc. | IMGN | 7 | 5 | 2 | 28.6 |
| Zogenix Inc | ZGNX | 8 | 7 | 1 | 12.5 |
| Arena Pharmaceuticals Inc | ARNA | 7 | 6 | 1 | 14.3 |
| Editas Medicine Inc | EDIT | 7 | 7 | 0 | 0.0 |
| Five Prime Therapeutics Inc | FPRX | 5 | 2 | 3 | 60.0 |
| Amphastar Pharmaceuticals Inc | AMPH | 8 | 8 | 0 | 0.0 |
| Opko Health Inc | OPK | 6 | 6 | 0 | 0.0 |
| Pliant Therapeutics Inc | PLRX | 1 | 1 | 0 | 0.0 |
| Endo International plc | ENDP | 6 | 5 | 1 | 16.7 |
| Travere Therapeutics Inc | TVTX | 2 | 2 | 0 | 0.0 |
| VBI Vaccines Inc. | VBIV | 7 | 7 | 0 | 0.0 |
| Marinus Pharmaceuticals Inc | MRNS | 6 | 5 | 1 | 16.7 |
| Karuna Therapeutics Inc | KRTX | 3 | 2 | 1 | 33.3 |
| Arvinas Inc | ARVN | 5 | 4 | 1 | 20.0 |
| G1 Therapeutics Inc | GTHX | 9 | 8 | 1 | 11.1 |
| Autolus Therapeutics plc - ADR | AUTL | 3 | 3 | 0 | 0.0 |
| Flexion Therapeutics Inc | FLXN | 6 | 4 | 2 | 33.3 |
| Beam Therapeutics Inc | BEAM | 7 | 4 | 3 | 42.9 |
| Aprea Therapeutics Inc | APRE | 1 | 1 | 0 | 0.0 |
| Arcus Biosciences Inc | RCUS | 3 | 2 | 1 | 33.3 |
| Codexis Inc. | CDXS | 11 | 8 | 3 | 27.3 |
| Ardelyx Inc | ARDX | 3 | 2 | 1 | 33.3 |
| Intellia Therapeutics Inc | NTLA | 6 | 5 | 1 | 16.7 |
| Seagen Inc | SGEN | 8 | 8 | 0 | 0.0 |
| Fusion Pharmaceuticals Inc | FUSN | 0 | 0 | 0 | 0.0 |
| Acadia Pharmaceuticals Inc | ACAD | 7 | 7 | 0 | 0.0 |
| Arcturus Therapeutics Holdings Inc | ARCT | 4 | 2 | 2 | 50.0 |
| Verastem Inc | VSTM | 7 | 6 | 1 | 14.3 |
| Macrogenics Inc | MGNX | 4 | 2 | 2 | 50.0 |
| Kiniksa Pharmaceuticals Ltd - Class A | KNSA | 4 | 3 | 1 | 25.0 |
| Akero Therapeutics Inc | AKRO | 3 | 2 | 1 | 33.3 |
| Fate Therapeutics Inc | FATE | 10 | 6 | 4 | 40.0 |
| Geron Corp. | GERN | 2 | 2 | 0 | 0.0 |
| Prothena Corporation plc | PRTA | 5 | 3 | 2 | 40.0 |
| Axsome Therapeutics Inc | AXSM | 3 | 2 | 1 | 33.3 |
| SIGA Technologies Inc | SIGA | 4 | 3 | 1 | 25.0 |
| Emergent Biosolutions Inc | EBS | 16 | 15 | 1 | 6.2 |
| Athenex Inc | ATNX | 6 | 6 | 0 | 0.0 |
| Revance Therapeutics Inc | RVNC | 7 | 5 | 2 | 28.6 |
| Eagle Pharmaceuticals Inc | EGRX | 7 | 7 | 0 | 0.0 |
| Larimar Therapeutics Inc | LRMR | 4 | 1 | 3 | 75.0 |
| Akouos Inc | AKUS | 0 | 0 | 0 | 0.0 |
| Allakos Inc | ALLK | 3 | 2 | 1 | 33.3 |
| Allogene Therapeutics Inc | ALLO | 4 | 3 | 1 | 25.0 |
| Guardant Health Inc | GH | 6 | 4 | 2 | 33.3 |
| Enanta Pharmaceuticals Inc | ENTA | 6 | 5 | 1 | 16.7 |
| Kezar Life Sciences Inc | KZR | 2 | 2 | 0 | 0.0 |
| Astrazeneca plc - ADR | AZN | 31 | 30 | 1 | 3.2 |
| Rhythm Pharmaceuticals Inc. | RYTM | 8 | 7 | 1 | 12.5 |
| Revolution Medicines Inc | RVMD | 4 | 4 | 0 | 0.0 |
| Nextcure Inc | NXTC | 0 | 0 | 0 | 0.0 |
| Regenxbio Inc | RGNX | 9 | 8 | 1 | 11.1 |
| Cardiff Oncology Inc | CRDF | 5 | 5 | 0 | 0.0 |
| Alector Inc | ALEC | 8 | 5 | 3 | 37.5 |
| Calithera Biosciences Inc | CALA | 2 | 2 | 0 | 0.0 |
| Stoke Therapeutics Inc | STOK | 8 | 6 | 2 | 25.0 |
| AvroBio Inc | AVRO | 5 | 5 | 0 | 0.0 |
| Athersys Inc | ATHX | 0 | 0 | 0 | 0.0 |
| China Biologic Products Holdings Inc | CBPO | 3 | 2 | 1 | 33.3 |
| Dynavax Technologies Corp. | DVAX | 10 | 9 | 1 | 10.0 |
| Rubius Therapeutics Inc | RUBY | 6 | 6 | 0 | 0.0 |
| Cortexyme Inc | CRTX | 4 | 4 | 0 | 0.0 |
| Tricida Inc | TCDA | 6 | 6 | 0 | 0.0 |
| Assembly Biosciences Inc | ASMB | 8 | 8 | 0 | 0.0 |
| Akebia Therapeutics Inc. | AKBA | 5 | 5 | 0 | 0.0 |
| BioNTech SE - ADR | BNTX | 24 | 21 | 3 | 12.5 |
| Krystal Biotech Inc | KRYS | 2 | 1 | 1 | 50.0 |
| Personalis Inc | PSNL | 4 | 3 | 1 | 25.0 |
| TG Therapeutics Inc | TGTX | 9 | 5 | 4 | 44.4 |
| Adicet Bio Inc | ACET | 3 | 3 | 0 | 0.0 |
| TherapeuticsMD Inc | TXMD | 6 | 5 | 1 | 16.7 |
| Biohaven Pharmaceutical Holding Company Ltd | BHVN | 12 | 10 | 2 | 16.7 |
| Cymabay Therapeutics Inc | CBAY | 4 | 2 | 2 | 50.0 |
| Syndax Pharmaceuticals Inc | SNDX | 3 | 2 | 1 | 33.3 |
| Concert Pharmaceuticals Inc | CNCE | 5 | 5 | 0 | 0.0 |
| Inovio Pharmaceuticals Inc | INO | 10 | 8 | 2 | 20.0 |
| Apellis Pharmaceuticals Inc | APLS | 6 | 5 | 1 | 16.7 |
| Compugen Ltd | CGEN | 9 | 8 | 1 | 11.1 |
| Spero Therapeutics Inc | SPRO | 8 | 7 | 1 | 12.5 |
| Cellectis - ADR | CLLS | 21 | 18 | 3 | 14.3 |
| Mersana Therapeutics Inc | MRSN | 3 | 2 | 1 | 33.3 |
| Constellation Pharmaceuticals Inc | CNST | 3 | 2 | 1 | 33.3 |
| Insmed Inc | INSM | 7 | 6 | 1 | 14.3 |
| Alkermes plc | ALKS | 4 | 2 | 2 | 50.0 |
| AC Immune SA | ACIU | 5 | 5 | 0 | 0.0 |
| Aeglea BioTherapeutics Inc | AGLE | 5 | 4 | 1 | 20.0 |
| Epizyme Inc | EPZM | 3 | 3 | 0 | 0.0 |
| Catalyst Pharmaceuticals Inc | CPRX | 3 | 3 | 0 | 0.0 |
| Supernus Pharmaceuticals Inc | SUPN | 5 | 3 | 2 | 40.0 |
| Cara Therapeutics Inc | CARA | 2 | 1 | 1 | 50.0 |
| Fulcrum Therapeutics Inc | FULC | 3 | 3 | 0 | 0.0 |
| Alx Oncology Holdings Inc | ALXO | 2 | 2 | 0 | 0.0 |
| Voyager Therapeutics Inc | VYGR | 3 | 3 | 0 | 0.0 |
| Kamada Ltd | KMDA | 19 | 17 | 2 | 10.5 |
| FibroGen Inc | FGEN | 7 | 6 | 1 | 14.3 |
| Intra-Cellular Therapies Inc | ITCI | 8 | 5 | 3 | 37.5 |
| Atara Biotherapeutics Inc | ATRA | 4 | 4 | 0 | 0.0 |
| Adaptimmune Therapeutics Plc - ADR | ADAP | 2 | 2 | 0 | 0.0 |
| AMGEN Inc. | AMGN | 8 | 8 | 0 | 0.0 |
| PDL Biopharma Inc | PDLI | 2 | 2 | 0 | 0.0 |
| Orchard Therapeutics plc - ADR | ORTX | 5 | 4 | 1 | 20.0 |
| Aurinia Pharmaceuticals Inc | AUPH | 3 | 3 | 0 | 0.0 |
| Caredx Inc | CDNA | 7 | 6 | 1 | 14.3 |
| Viking Therapeutics Inc | VKTX | 6 | 6 | 0 | 0.0 |
| Turning Point Therapeutics Inc | TPTX | 4 | 4 | 0 | 0.0 |
| BeiGene Ltd - ADR | BGNE | 12 | 7 | 5 | 41.7 |
| Theravance Biopharma Inc | TBPH | 1 | 1 | 0 | 0.0 |
| Mirati Therapeutics Inc | MRTX | 5 | 3 | 2 | 40.0 |
| Karyopharm Therapeutics Inc | KPTI | 5 | 5 | 0 | 0.0 |
| Agenus Inc | AGEN | 0 | 0 | 0 | 0.0 |
| Rocket Pharmaceuticals Inc | RCKT | 5 | 4 | 1 | 20.0 |
| KalVista Pharmaceuticals Inc | KALV | 6 | 4 | 2 | 33.3 |
| Cabaletta Bio Inc | CABA | 2 | 1 | 1 | 50.0 |
| Unity Biotechnology Inc | UBX | 8 | 6 | 2 | 25.0 |
| Y-Mabs Therapeutics Inc | YMAB | 3 | 2 | 1 | 33.3 |
| Nurix Therapeutics Inc | NRIX | 2 | 2 | 0 | 0.0 |
| Forma Therapeutics Holdings Inc | FMTX | 0 | 0 | 0 | 0.0 |
| IGM Biosciences Inc | IGMS | 5 | 5 | 0 | 0.0 |
| uniQure N.V. | QURE | 9 | 9 | 0 | 0.0 |
| Galapagos NV - ADR | GLPG | 41 | 40 | 1 | 2.4 |
| Wave Life Sciences Ltd. | WVE | 0 | 0 | 0 | 0.0 |
| Sanofi - ADR | SNY | 28 | 27 | 1 | 3.6 |
| Relay Therapeutics Inc | RLAY | 1 | 1 | 0 | 0.0 |
| Illumina Inc | ILMN | 12 | 10 | 2 | 16.7 |
| Passage Bio Inc | PASG | 2 | 2 | 0 | 0.0 |
| Seres Therapeutics Inc | MCRB | 5 | 4 | 1 | 20.0 |
| Celldex Therapeutics Inc. | CLDX | 7 | 5 | 2 | 28.6 |
| ChemoCentryx Inc | CCXI | 2 | 2 | 0 | 0.0 |
| Ascendis Pharma A/S - ADR | ASND | 3 | 3 | 0 | 0.0 |
| Frequency Therapeutics Inc | FREQ | 2 | 2 | 0 | 0.0 |
| Osmotica Pharmaceuticals Plc | OSMT | 5 | 5 | 0 | 0.0 |
| Novavax, Inc. | NVAX | 15 | 8 | 7 | 46.7 |
| Sarepta Therapeutics Inc | SRPT | 7 | 7 | 0 | 0.0 |
| Atreca Inc - Class A | BCEL | 3 | 2 | 1 | 33.3 |
| Intercept Pharmaceuticals Inc | ICPT | 6 | 6 | 0 | 0.0 |
| Aerie Pharmaceuticals Inc | AERI | 1 | 1 | 0 | 0.0 |
| Legend Biotech Corp - ADR | LEGN | 2 | 2 | 0 | 0.0 |
| Biodelivery Sciences International | BDSI | 6 | 6 | 0 | 0.0 |
| Vir Biotechnology Inc | VIR | 7 | 5 | 2 | 28.6 |
| Ultragenyx Pharmaceutical Inc. | RARE | 6 | 4 | 2 | 33.3 |
| Pacific Biosciences of California Inc | PACB | 13 | 8 | 5 | 38.5 |
| Jazz Pharmaceuticals plc | JAZZ | 8 | 6 | 2 | 25.0 |
| Ziopharm Oncology, Inc. | ZIOP | 2 | 2 | 0 | 0.0 |
| Abbvie Inc | ABBV | 11 | 8 | 3 | 27.3 |
| Cue Biopharma Inc | CUE | 5 | 5 | 0 | 0.0 |
| Mannkind Corp | MNKD | 4 | 3 | 1 | 25.0 |
| Nektar Therapeutics | NKTR | 8 | 7 | 1 | 12.5 |
| Anika Therapeutics Inc. | ANIK | 7 | 6 | 1 | 14.3 |
| Kala Pharmaceuticals Inc | KALA | 4 | 4 | 0 | 0.0 |
| Exelixis Inc | EXEL | 9 | 8 | 1 | 11.1 |
| BioXcel Therapeutics Inc | BTAI | 3 | 3 | 0 | 0.0 |
| XBiotech Inc | XBIT | 3 | 3 | 0 | 0.0 |
| Immunic Inc | IMUX | 13 | 12 | 1 | 7.7 |
| Avidity Biosciences Inc | RNA | 3 | 3 | 0 | 0.0 |
| GW Pharmaceuticals - ADR | GWPH | 10 | 7 | 3 | 30.0 |
| Odonate Therapeutics Inc | ODT | 5 | 3 | 2 | 40.0 |
| Castle Biosciences Inc | CSTL | 3 | 3 | 0 | 0.0 |
| Gilead Sciences, Inc. | GILD | 5 | 5 | 0 | 0.0 |
| Vericel Corp | VCEL | 9 | 3 | 6 | 66.7 |
| Vaxart Inc | VXRT | 11 | 9 | 2 | 18.2 |
| Immunovant Inc | IMVT | 5 | 5 | 0 | 0.0 |
| Zentalis Pharmaceuticals Inc | ZNTL | 1 | 1 | 0 | 0.0 |
| Arbutus Biopharma Corp | ABUS | 4 | 2 | 2 | 50.0 |
| Relmada Therapeutics Inc | RLMD | 2 | 2 | 0 | 0.0 |
| AlloVir Inc | ALVR | 0 | 0 | 0 | 0.0 |
| Regeneron Pharmaceuticals, Inc. | REGN | 9 | 9 | 0 | 0.0 |
| Ideaya Biosciences Inc | IDYA | 5 | 4 | 1 | 20.0 |
| Affimed N.V. | AFMD | 3 | 3 | 0 | 0.0 |
| Incyte Corp. | INCY | 9 | 9 | 0 | 0.0 |
| Arcutis Biotherapeutics Inc | ARQT | 4 | 1 | 3 | 75.0 |
| Argen X SE - ADR | ARGX | 29 | 23 | 6 | 20.7 |
| Xenon Pharmaceuticals Inc | XENE | 0 | 0 | 0 | 0.0 |
| Neoleukin Therapeutics Inc | NLTX | 4 | 4 | 0 | 0.0 |
| Viela Bio Inc | VIE | 3 | 2 | 1 | 33.3 |
| Puma Biotechnology Inc | PBYI | 1 | 1 | 0 | 0.0 |
| Xeris Pharmaceuticals Inc | XERS | 8 | 8 | 0 | 0.0 |
| PTC Therapeutics Inc | PTCT | 2 | 1 | 1 | 50.0 |
| Redhill Biopharma - ADR | RDHL | 9 | 7 | 2 | 22.2 |
| Myriad Genetics, Inc. | MYGN | 5 | 4 | 1 | 20.0 |
| Keros Therapeutics Inc | KROS | 0 | 0 | 0 | 0.0 |
| Kodiak Sciences Inc | KOD | 9 | 8 | 1 | 11.1 |
| Kaleido Biosciences Inc | KLDO | 4 | 3 | 1 | 25.0 |
| Pacira BioSciences Inc | PCRX | 4 | 3 | 1 | 25.0 |
| Kura Oncology Inc | KURA | 7 | 5 | 2 | 28.6 |
| Deciphera Pharmaceuticals Inc | DCPH | 5 | 5 | 0 | 0.0 |
| Sangamo Therapeutics Inc | SGMO | 5 | 5 | 0 | 0.0 |
| Acceleron Pharma Inc | XLRN | 6 | 4 | 2 | 33.3 |
| Royalty Pharma plc - Class A | RPRX | 3 | 1 | 2 | 66.7 |
| Annexon Inc | ANNX | 0 | 0 | 0 | 0.0 |
| CRISPR Therapeutics AG | CRSP | 11 | 8 | 3 | 27.3 |
| Repare Therapeutics Inc | RPTX | 2 | 1 | 1 | 50.0 |
| Inozyme Pharma Inc | INZY | 0 | 0 | 0 | 0.0 |
| RAPT Therapeutics Inc | RAPT | 3 | 2 | 1 | 33.3 |
| Global Blood Therapeutics Inc. | GBT | 6 | 6 | 0 | 0.0 |
| Luminex Corp | LMNX | 9 | 9 | 0 | 0.0 |
| Iovance Biotherapeutics Inc | IOVA | 7 | 6 | 1 | 14.3 |
| Dicerna Pharmaceuticals Inc | DRNA | 8 | 5 | 3 | 37.5 |
| Ngm Biopharmaceuticals Inc | NGM | 3 | 2 | 1 | 33.3 |
| Medicinova Inc | MNOV | 8 | 6 | 2 | 25.0 |
| Altimmune Inc | ALT | 7 | 5 | 2 | 28.6 |
| Ionis Pharmaceuticals Inc | IONS | 11 | 9 | 2 | 18.2 |
| Chiasma Inc | CHMA | 3 | 2 | 1 | 33.3 |
| I-Mab - ADR | IMAB | 4 | 4 | 0 | 0.0 |
| Jounce Therapeutics Inc | JNCE | 3 | 2 | 1 | 33.3 |
| Ligand Pharmaceuticals, Inc. - Class B | LGND | 7 | 7 | 0 | 0.0 |
| Reata Pharmaceuticals Inc - Class A | RETA | 6 | 6 | 0 | 0.0 |
| Avadel Pharmaceuticals plc - ADR | AVDL | 1 | 1 | 0 | 0.0 |
| Amarin Corp - ADR | AMRN | 4 | 3 | 1 | 25.0 |
| Xencor Inc | XNCR | 7 | 7 | 0 | 0.0 |
| Provention Bio Inc | PRVB | 4 | 4 | 0 | 0.0 |
| Precision Biosciences Inc | DTIL | 4 | 3 | 1 | 25.0 |
| Vaxcyte Inc | PCVX | 2 | 2 | 0 | 0.0 |
| Gamida Cell Ltd | GMDA | 9 | 5 | 4 | 44.4 |
| MeiraGTx Holdings plc | MGTX | 4 | 4 | 0 | 0.0 |
| Cytokinetics Inc | CYTK | 7 | 5 | 2 | 28.6 |
| Tcr2 Therapeutics Inc | TCRR | 6 | 3 | 3 | 50.0 |
| Moderna Inc | MRNA | 17 | 12 | 5 | 29.4 |
| Alexion Pharmaceuticals Inc. | ALXN | 11 | 10 | 1 | 9.1 |
| Rigel Pharmaceuticals | RIGL | 6 | 5 | 1 | 16.7 |
| Clovis Oncology Inc | CLVS | 0 | 0 | 0 | 0.0 |
| Heron Therapeutics Inc | HRTX | 5 | 4 | 1 | 20.0 |
| Summit Therapeutics Inc | SMMT | 5 | 2 | 3 | 60.0 |
| Sage Therapeutics Inc | SAGE | 8 | 5 | 3 | 37.5 |
| Applied Therapeutics Inc | APLT | 2 | 2 | 0 | 0.0 |
| Neurocrine Biosciences, Inc. | NBIX | 6 | 6 | 0 | 0.0 |
| Bluebird bio Inc | BLUE | 5 | 5 | 0 | 0.0 |
| Translate Bio Inc | TBIO | 11 | 10 | 1 | 9.1 |
| Albireo Pharma Inc | ALBO | 5 | 2 | 3 | 60.0 |
| CytomX Therapeutics Inc | CTMX | 3 | 1 | 2 | 66.7 |
| Selecta Biosciences Inc | SELB | 5 | 4 | 1 | 20.0 |
| Natera Inc | NTRA | 9 | 5 | 4 | 44.4 |
| Denali Therapeutics Inc | DNLI | 7 | 6 | 1 | 14.3 |
| VYNE Therapeutics Inc | VYNE | 5 | 4 | 1 | 20.0 |
| Eiger BioPharmaceuticals Inc | EIGR | 6 | 5 | 1 | 16.7 |
| AnaptysBio Inc | ANAB | 6 | 5 | 1 | 16.7 |
| Innoviva Inc | INVA | 5 | 5 | 0 | 0.0 |
| Magenta Therapeutics Inc | MGTA | 3 | 3 | 0 | 0.0 |
| Paratek Pharmaceuticals Inc. | PRTK | 4 | 2 | 2 | 50.0 |
| Exact Sciences Corp. | EXAS | 7 | 4 | 3 | 42.9 |
| Generation Bio Co | GBIO | 1 | 0 | 1 | 100.0 |
| PetIQ Inc - Class A | PETQ | 9 | 6 | 3 | 33.3 |
| Chinook Therapeutics Inc | KDNY | 4 | 3 | 1 | 25.0 |
| PRA Health Sciences Inc | PRAH | 10 | 8 | 2 | 20.0 |
| Syros Pharmaceuticals Inc. | SYRS | 5 | 5 | 0 | 0.0 |
| ORIC Pharmaceuticals Inc | ORIC | 2 | 2 | 0 | 0.0 |
| Pandion Therapeutics Inc | PAND | 4 | 3 | 1 | 25.0 |
| Coherus Biosciences Inc | CHRS | 3 | 3 | 0 | 0.0 |
| NantKwest Inc | NK | 8 | 6 | 2 | 25.0 |
| Genmab - ADR | GMAB | 40 | 34 | 6 | 15.0 |
| Madrigal Pharmaceuticals Inc | MDGL | 8 | 3 | 5 | 62.5 |
| Replimune Group Inc | REPL | 2 | 2 | 0 | 0.0 |
| AVITA Medical Inc | RCEL | 28 | 26 | 2 | 7.1 |
| Veracyte Inc | VCYT | 9 | 9 | 0 | 0.0 |
| Syneos Health Inc - Class A | SYNH | 9 | 7 | 2 | 22.2 |
| Crinetics Pharmaceuticals Inc | CRNX | 0 | 0 | 0 | 0.0 |
| ANI Pharmaceuticals Inc | ANIP | 8 | 8 | 0 | 0.0 |
| Radius Health Inc. | RDUS | 6 | 6 | 0 | 0.0 |
| Cel-Sci Corp. | CVM | 3 | 2 | 1 | 33.3 |
| Ironwood Pharmaceuticals Inc - Class A | IRWD | 3 | 2 | 1 | 33.3 |
| Surface Oncology Inc | SURF | 6 | 3 | 3 | 50.0 |
| Vertex Pharmaceuticals, Inc. | VRTX | 2 | 2 | 0 | 0.0 |
| Zai Lab Limited - ADR | ZLAB | 18 | 14 | 4 | 22.2 |
| Sorrento Therapeutics Inc | SRNE | 15 | 13 | 2 | 13.3 |
| Horizon Therapeutics Plc | HZNP | 12 | 6 | 6 | 50.0 |
| Nkarta Inc | NKTX | 0 | 0 | 0 | 0.0 |
| IVERIC bio Inc | ISEE | 8 | 6 | 2 | 25.0 |
| Scholar Rock Holding Corp | SRRK | 3 | 2 | 1 | 33.3 |
| Gossamer Bio Inc | GOSS | 0 | 0 | 0 | 0.0 |
| BridgeBio Pharma Inc | BBIO | 4 | 3 | 1 | 25.0 |
| Biogen Inc | BIIB | 11 | 10 | 1 | 9.1 |
| Kadmon Holdings Inc | KDMN | 3 | 3 | 0 | 0.0 |
| Arrowhead Pharmaceuticals Inc. | ARWR | 7 | 5 | 2 | 28.6 |
| Spectrum Pharmaceuticals, Inc. | SPPI | 7 | 6 | 1 | 14.3 |
| Agios Pharmaceuticals Inc | AGIO | 6 | 5 | 1 | 16.7 |
| Alnylam Pharmaceuticals Inc | ALNY | 10 | 9 | 1 | 10.0 |
| Precigen Inc | PGEN | 4 | 4 | 0 | 0.0 |
| Ocular Therapeutix Inc | OCUL | 6 | 4 | 2 | 33.3 |
| Homology Medicines Inc | FIXX | 4 | 3 | 1 | 25.0 |
| ITeos Therapeutics Inc | ITOS | 0 | 0 | 0 | 0.0 |
| SpringWorks Therapeutics Inc | SWTX | 1 | 1 | 0 | 0.0 |
| Medpace Holdings Inc | MEDP | 12 | 9 | 3 | 25.0 |
| Vanda Pharmaceuticals Inc | VNDA | 4 | 3 | 1 | 25.0 |
| Black Diamond Therapeutics Inc | BDTX | 3 | 2 | 1 | 33.3 |
| United Therapeutics Corp | UTHR | 6 | 4 | 2 | 33.3 |
Gap Statistics:
Must-Read Books on Technical Analysis:
Japanese Candlestick Charting Techniques by Steve Nison
Technical Analysis of the Financial Markets by John Murphy
